Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial

  • Robert A. Wise,
  • Janet T. Holbrook,
  • Gerard Criner,
  • Sanjay Sethi,
  • Sobharani Rayapudi,
  • Kuladeep R. Sudini,
  • Elizabeth A. Sugar,
  • Alyce Burke,
  • Rajesh Thimmulappa,
  • Anju Singh,
  • Paul Talalay,
  • Jed W. Fahey,
  • Charles S. Berenson,
  • Michael R. Jacobs,
  • Shyam Biswal,
  •  [ ... ],
  • on behalf of Broccoli Sprout Extract Trial Research Group
  • [ view all ]
  • [ view less ]
  • Article
  • Metrics
  • Comments
  • Media Coverage

The following information is missing from the Funding section: Author SB is partly supported by the Flight Attendant Medical Research Institute Clinical Innovator Award.

Reference

  1. 1. Wise RA, Holbrook JT, Criner G, Sethi S, Rayapudi S, Sudini KR, et al. (2016) Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial. PLoS ONE 11(11): e0163716. pmid:27832073

Citation: Wise RA, Holbrook JT, Criner G, Sethi S, Rayapudi S, Sudini KR, et al. (2017) Correction: Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial. PLoS ONE 12(3): e0175077. https://doi.org/10.1371/journal.pone.0175077

Published: March 28, 2017

Copyright: © 2017 Wise et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.